A Study to Improve the Vitamin A and Iodine Status of Pregnant Women through a Multiple Micronutrient Fortified Salt

Table 3

Prevalence of inflammation, CRP, and AGP in the experimental and control groups in the three trimesters.

	Experimental group (multiple fortified salt) N = 151						Control group; N = 150
By trimester:	No inflammation%	Incubation#%	Early convalescence§%	Late convalescence¥; %	C-reactive protein mg/L	Alpha glycoprotein g/L	No inflammation; %	Incubation#%	Early convalescence§; %	Late convalescence¥ %	C-reactive protein mg/L ©	Alpha glycoprotein g/L©
First trimester	42.4	20.5	19.2	17.9	4.41 ± 3.41	0.96 ± 0.20	42	16.7	20	21.3	4.35 ± 4.54	0.97 ± 0.25
Second trimester	48.3	41.7	8	2	5.54 ± 3.80	0.76 ± 0.18	71.3	28	0.7	0	4.04 ± 3.18	0.58 ± 0.13
Third trimester	59.6	35.8	4	0.6	4.79 ± 3.58	0.63 ± 0.16	54.7	32.7	10.6	2	5.37 ± 3.62	0.74 ± 0.23

No inflammation is seen when there is no increase in the acute phase proteins; ^#Incubation (when only the CRP is increased (CRP>5 mg/L) and AGP is normal); ^§Early convalescence (when both the CRP and AGP are increased (CRP>5 mg/L and AGP>1 g/L)); ^¥ Late convalescence (when CRP is normal and AGP is raised (AGP>1 g/L)); ©-value group x time Anova repeat measures .